{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:10:27Z","timestamp":1768633827674,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","award":["H2020-SC1-2017-755021"],"award-info":[{"award-number":["H2020-SC1-2017-755021"]}],"id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.rmed.2025.108238","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:02:06Z","timestamp":1752598926000},"page":"108238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["N1303K (p.Asn1303Lys) variant: Expanding frontiers in the treatment of cystic fibrosis"],"prefix":"10.1016","volume":"246","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-9274","authenticated-orcid":false,"given":"Joana","family":"Pacheco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9235-9453","authenticated-orcid":false,"given":"Leonor","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Boaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2994-3045","authenticated-orcid":false,"given":"Ana\u2009Luisa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-4820","authenticated-orcid":false,"given":"Claudia\u2009S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3713-7089","authenticated-orcid":false,"given":"Violeta","family":"Railean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris\u2009AL.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-7521","authenticated-orcid":false,"given":"Ines","family":"Pankonien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-8630","authenticated-orcid":false,"given":"Margarida\u2009D.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelina","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108238_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02437-2022","article-title":"The French compassionate program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant","author":"Burgel","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108238_bib2","unstructured":"Patient Registry 2022 | ECFS n.d. https:\/\/www.ecfs.eu\/projects\/ecfs-patient-registry\/annual-reports (accessed July 1, 2024). page 33."},{"key":"10.1016\/j.rmed.2025.108238_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00110-2023","article-title":"Theratyping cystic fibrosis patients to guide elexacaftor\/tezacaftor\/ivacaftor out-of-label prescription","volume":"62","author":"Dreano","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108238_bib5","unstructured":"The clinical and functional translation of CFTR (CFTR2) n.d. http:\/\/cftr2.org\/(accessed August 2, 2024)."},{"key":"10.1016\/j.rmed.2025.108238_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-13-91","article-title":"Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility","volume":"13","author":"Servidoni","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.rmed.2025.108238_bib7","article-title":"Protocol for application, standardization and validation of the forskolin-induced swelling assay in cystic fibrosis human Colon organoids","volume":"1","author":"Vonk","year":"2020","journal-title":"STAR Protoc"},{"key":"10.1016\/j.rmed.2025.108238_bib8","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1093\/bioinformatics\/btaa1073","article-title":"An open-source high-content analysis workflow for CFTR function measurements using the forskolin-induced swelling assay","volume":"36","author":"Hagemeijer","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.rmed.2025.108238_bib9","unstructured":"Kaftrio | european medicines agency (EMA) n.d. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kaftrio-epar-product-information_en.pdf (accessed August 6, 2024)."},{"key":"10.1016\/j.rmed.2025.108238_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.rmed.2025.108238_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02426-2019","article-title":"Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis","volume":"57","author":"Ramalho","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108238_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1155705","article-title":"Personalized medicine: function of CFTR variant p.Arg334Trp is rescued by currently available CFTR modulators","volume":"10","author":"Railean","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.rmed.2025.108238_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914539","article-title":"CFTR function restoration upon elexacaftor\/tezacaftor\/ivacaftor treatment in patient-derived intestinal organoids with rare CFTR genotypes","volume":"24","author":"Lefferts","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2025.108238_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512365","article-title":"Personalized CFTR modulator therapy for G85E and N1303K homozygous patients with cystic fibrosis","volume":"24","author":"Graeber","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2025.108238_bib15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jcf.2023.06.001","article-title":"Clinical and functional efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis carrying the N1303K mutation","volume":"22","author":"Sadras","year":"2023","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2025.108238_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jcf.2024.02.006","article-title":"In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis","volume":"23","author":"Bihler","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2025.108238_bib17","unstructured":"Patient Registry | Cystic fibrosis foundation n.d. https:\/\/www.cff.org\/medical-professionals\/patient-registry (accessed August 6, 2024)."},{"key":"10.1016\/j.rmed.2025.108238_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12890-018-0594-8","article-title":"Implementation of a successful eradication protocol for Burkholderia cepacia complex in cystic fibrosis patients","volume":"18","author":"Garcia","year":"2018","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108238_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12941-019-0306-0","article-title":"Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update","volume":"18","author":"Devanga Ragupathi","year":"2019","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.rmed.2025.108238_bib20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the international society for heart and lung transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.rmed.2025.108238_bib21","series-title":"Cancidas (Caspofungin Acetate) for Injection, for Intravenous Use","year":"2021"},{"key":"10.1016\/j.rmed.2025.108238_bib22","article-title":"Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: a case report","volume":"40","author":"Dagenais","year":"2022","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.rmed.2025.108238_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jcf.2008.02.005","article-title":"Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy","volume":"7","author":"Weidmann","year":"2008","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:17:55Z","timestamp":1762337875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125003014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":22,"alternative-id":["S0954611125003014"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108238","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N1303K (p.Asn1303Lys) variant: Expanding frontiers in the treatment of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108238"}}